Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 3 | 3 | 1 | — | 3 | 9 |
Neoplasms | D009369 | — | C80 | — | 1 | 1 | — | — | 2 |
Carcinoid tumor | D002276 | — | D3A.00 | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pheochromocytoma | D010673 | — | — | 1 | 2 | — | — | — | 2 |
Paraganglioma | D010235 | — | — | 1 | 2 | — | — | — | 2 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | — | — | — | 1 |
Malignant carcinoid syndrome | D008303 | — | E34.0 | — | 1 | — | — | — | 1 |
Carcinoid heart disease | D002275 | EFO_1001769 | E34.01 | — | 1 | — | — | — | 1 |
Serotonin syndrome | D020230 | EFO_1001842 | G90.81 | — | 1 | — | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroblastoma | D009447 | EFO_0000621 | — | 1 | — | — | — | — | 1 |
Thymoma | D013945 | — | — | 1 | — | — | — | — | 1 |
Mesothelioma | D008654 | — | C45 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcoidosis | D012507 | EFO_0000690 | D80-D89 | — | — | — | — | 1 | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | — | 1 | 1 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 1 | 1 |
Intestinal neoplasms | D007414 | — | C26.0 | — | — | — | — | 1 | 1 |
Carcinoma | D002277 | — | C80.0 | — | — | — | — | 1 | 1 |
Neuroendocrine carcinoma | D018278 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Somatostatin |
INN | somatostatin |
Description | SOMATOSTATIN |
Classification | Protein |
Drug class | growth hormone derivatives; enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O |
PDB | — |
CAS-ID | 38916-34-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1823872 |
ChEBI ID | 64628 |
PubChem CID | — |
DrugBank | — |
UNII ID | 6E20216Q0L (ChemIDplus, GSRS) |